Jubilant Pharmova's Stock Reaches 52-Week High, Recognized as 'Strong Buy' by MarketsMOJO
Jubilant Pharmova's stock has been on a strong upward trend, reaching a 52-week high on November 4th, 2024. The company has also been consistently performing well, with a 'Strong Buy' rating from MarketsMojo and a spot on the Reliable Performers list. Despite a slight underperformance in the sector, the stock has shown a 212.97% increase in the past year, showcasing its strong financials and market position. With a diverse portfolio of pharmaceuticals and drugs, Jubilant Pharmova is a top contender in the largecap pharmaceutical industry.
Jubilant Pharmova, a leading pharmaceutical company, has been making waves in the industry with its recent stock performance. On November 4th, 2024, the company's stock price reached a 52-week high, indicating a strong upward trend. This positive momentum has been recognized by MarketsMOJO, who have given the stock a 'Strong Buy' rating.
Jubilant Pharmova's stock has also been consistently performing well, being a part of the Reliable Performers list on MarketsMOJO since October 31st, 2024. The company's stock price hit an all-time high of Rs. 1297.75 on the same day, showcasing its strong growth potential.
Despite a slight underperformance in the sector today, Jubilant Pharmova's stock has been on an upward trend, with a 212.97% increase in the past year compared to Sensex's 22.76% performance. This is a testament to the company's strong financials and market position.
Intraday, the stock touched a low of Rs. 1244.35, but has been trading higher than its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. This indicates a positive trend and potential for further growth.
Jubilant Pharmova's success can be attributed to its strong portfolio of pharmaceuticals and drugs, catering to a wide range of medical needs. With its consistent performance and positive outlook, the company is definitely one to watch in the largecap pharmaceutical industry.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
